About Us

Luye Pharma Group (02186.HK), a member of Luye Life Sciences Group, is an international pharmaceutical company dedicated to the R&D, manufacturing and sale of innovative medications.

Luye Pharma Announces 2023 Financial Results:Showing solid sales growth and improved financial structure


Shanghai, March 27, 2024 – Luye Pharma Group (2186.HK) today announced its 2023 financial results and latest developments. During the reporting period, the group's revenue was approximately RMB 6.14 billion, up 2.7 percent ...

March 27,2024

Luye Pharma’s Innovative Drug Zepzelca® (Lurbinectedin) Launched in Hong Kong and Macao

- Reshaping the landscape for the second-line treatments of Small Cell Lung Cancer - Hong Kong and Macao, March 7, 2024 – A symposium called the New Treatment Paradigm for Small Cell Lung Cancer (SCLC) organized by the Hong Kong Cancer ...

March 07,2024

Read More


Employee Stories

Upholding the philosophy of “Employee Development”,
Luye Pharma regards employees as the most valuable resources of the company